Eagle's Landing Diabetes & Endocrinology is categorized under Medical Labs in Stockbridge, GA and active since 2003.
Eagle's Landing Diabetes & Endocrinology was established in 2003, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number by the NAICS.
If you are seeking more information, feel free to contact Ronald Watts at the company’s single location by writing to 1050 Eagles Landing Parkway
Suite 302, Stockbridge, Georgia GA 30281 or by phoning (770) 389-9494. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Eagle's Landing Diabetes & Endocrinology |
| Contact Person: | Ronald Watts |
| Address: | 1050 Eagles Landing Parkway Suite 302, Stockbridge, Georgia 30281 |
| Phone Number: | (770) 389-9494 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| Share This Business: |
Eagle's Landing Diabetes & Endocrinology was started in 2003 to provide professional Medical Labs under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Ronald Watts for inquiries that concern Eagle's Landing Diabetes & Endocrinology by calling the company number (770) 389-9494, as your correspondence is most welcome.
Additionally, the physical location of the single location of Eagle's Landing Diabetes & Endocrinology can be found at the coordinates 33.51274,-84.21664 as well as the street address 1050 Eagles Landing Parkway
Suite 302 in Stockbridge, Georgia 30281.
For its online presence, you may visit Eagle's Landing Diabetes & Endocrinology’s website at and engage with its social media outlets through on Twitter and on Facebook.